[EN] SPIROALKENE CARBOXAMIDE DERIVATIVES AND THEIR USE AS CHEMOKINE RECEPTOR MODULATORS [FR] DÉRIVÉS DE SPIROALCÈNECARBOXAMIDE ET LEUR UTILISATION COMME MODULATEURS DE RÉCEPTEURS DE CHEMOKINES
[EN] SPIROALKENE CARBOXAMIDE DERIVATIVES AND THEIR USE AS CHEMOKINE RECEPTOR MODULATORS<br/>[FR] DÉRIVÉS DE SPIROALCÈNECARBOXAMIDE ET LEUR UTILISATION COMME MODULATEURS DE RÉCEPTEURS DE CHEMOKINES
申请人:ARES TRADING SA
公开号:WO2012130915A1
公开(公告)日:2012-10-04
The present invention is directed to compounds of Formula (I) below, which are antagonists to the chemoattractant cytokine receptor 2 (CCR2), and/or 5 (CCR5), pharmaceutical compositions, and methods for use thereof.
[EN] BENZYLIDENE THIAZOLIDINEDIONES AND THEIR USE AS ANTIMYCOTIC AGENTS<br/>[FR] BENZYLIDENE-THIAZOLIDINEDIONES ET LEUR UTILISATION EN TANT QU'AGENTS ANTIMYCOSIQUES
申请人:OXFORD GLYCOSCIENCES UK LTD
公开号:WO2003070239A1
公开(公告)日:2003-08-28
The present invention relates to thiazolidine derivatives of formula (I), methods for their preparation, pharmaceutical compositions containing them and their use in medicine, specifically in the treatment of fungal infections, wherein A is O or S; Q is (CH2)m-CH(R1)-(CH2)n; m is 0, 1, 2 or 3; n is 0, 1 or 2; R is OR6 or NHR8;and R1 to R5 represent various substituents.
Spiroalkene carboxamide derivatives and their use as chemokine receptor modulators
申请人:Ares Trading SA
公开号:EP2508526A1
公开(公告)日:2012-10-10
The present invention is directed to compounds of Formula (I) below, which are antagonists to the chemoattractant cytokine receptor 2 (CCR2), and/or 5 (CCR5), pharmaceutical compositions, and methods for use thereof.